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Abstract
Melanin protects the skin and eyes from the harmful effects of UV irradiation, protects neural cells from toxic insults, and is
required for sound conduction in the inner ear. Aberrant regulation of melanogenesis underlies skin disorders (melasma and
vitiligo), neurologic disorders (Parkinson’s disease), auditory disorders (Waardenburg’s syndrome), and opthalmologic
disorders (age related macular degeneration). Much of the core synthetic machinery driving melanin production has been
identified; however, the spectrum of gene products participating in melanogenesis in different physiological niches is
poorly understood. Functional genomics based on RNA-mediated interference (RNAi) provides the opportunity to derive
unbiased comprehensive collections of pharmaceutically tractable single gene targets supporting melanin production. In
this study, we have combined a high-throughput, cell-based, one-well/one-gene screening platform with a genome-wide
arrayed synthetic library of chemically synthesized, small interfering RNAs to identify novel biological pathways that govern
melanin biogenesis in human melanocytes. Ninety-two novel genes that support pigment production were identified with a
low false discovery rate. Secondary validation and preliminary mechanistic studies identified a large panel of targets that
converge on tyrosinase expression and stability. Small molecule inhibition of a family of gene products in this class was
sufficient to impair chronic tyrosinase expression in pigmented melanoma cells and UV-induced tyrosinase expression in
primary melanocytes. Isolation of molecular machinery known to support autophagosome biosynthesis from this screen,
together with in vitro and in vivo validation, exposed a close functional relationship between melanogenesis and
autophagy. In summary, these studies illustrate the power of RNAi-based functional genomics to identify novel genes,
pathways, and pharmacologic agents that impact a biological phenotype and operate outside of preconceived mechanistic
relationships.
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Introduction
Significant effort has been focused on identifying the molecular
etiology for pigment variation in skin [1]. 127 mouse coat color
genes have been identified [2], 68 of these genes have human
homologues, and 29 of these homologues impact pigmentation in
humans. Genetic mapping studies have identified a limited set of
genes responsible for skin and eye color variability [3]. Pigment
production involves the concerted actions of transcriptional,
translational, and intracellular trafficking machinery [4]. MITF,
the master regulator of melanogenesis in the mouse hair follicle
[5], activates the transcription of tyrosinase, the rate limiting step
in melanogenesis [5]. Tyrosinase is translated in the endoplasmic
reticulum and is glycosylated in the Golgi apparatus [6].
Tyrosinase activity is restricted to the melanosome, a melanin
specific organelle of poorly defined origin [7,8]. While the subtle
variation in human skin color is thought to be the result of the
complex interaction of multiple genes, the majority of mouse
mutants described have segmental or complete absence of pigment
[9]. Recent studies have identified partial loss of function
mutations that impact the shade of melanin in zebrafish and
human skin [10], but the spectrum of gene targets that regulate
pigment shade is unknown. Melanin is expressed in different end
organs conferring different functions. Melanin protects the skin,
eyes [1], and brain from toxic insults [11]. Melanin in the inner
ear impacts sound conduction [12]. Loss of melanin is thought to
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and Parkinson’s disease [14]. Additionally, melanin is aberrantly
regulated in human skin disorders such as vitiligo and melasma.
Harnessing the molecular mechanisms that regulate melanogen-
esis to selectively modulate melanin production in the skin, eye, or
brain could lead to novel treatments for multiple human
pathologies. Pharmacologic modulation of melanin production
has primarily focused on identifying inhibitors of tyrosinase, the
rate limiting step in pigment production [15]. Currently utilized
tyrosinase inhibitors are clinically effective, but are carcinogenic in
animal studies [16]. Pharmacologic agonists that stimulate
pigmentation in human tissues remain to be identified. A better
understanding of the molecular network governing pigment
production in the human epidermis is indicated to aid design of
agents that inhibit or stimulate pigmentation in human skin.
Results/Discussion
Studies to determine the key molecular regulators of melanogen-
esis in human melanocytes have been hampered by the innate
fragility of these cells and the factthat theyproducescant amounts of
pigment in culture [17,18]. To identify novel regulators of
melanogenesis in human cells, we utilized MNT-1 melanoma cells
to screen a genome-wide synthetic siRNA library for single-gene loci
that support melanocyte pigmentation. MNT-1 cells produce
substantial amounts of melanin in culture, have a gene expression
profile that is most similar to normal melanocytes [19], and have
been used by others to identify pigment regulatory mechanisms that
govern normal melanogenesis [20–23]. We employed a previously
described [24] Dharmacon siRNA library of 84,508 siRNAs
corresponding to four unique siRNA duplexes, targeting each of
the 21,127 unique human genes arrayed in a one-gene/one-well
format on 96 well microtiter plates. A spectrophotometric melanin
quantitation assay was coupled with an ATP-dependent lumines-
cence cell viability assay (CellTiter-Glo) to eliminate siRNAs that
decrease melanin production as a consequence of impacts on either
cell proliferation or cell survival. Using tyrosinase depletion as a
positive control, we determined that a 5-day post-transfection
incubation period was optimal for quantitative detection of impaired
melaninproduction (Figure S1). Otherstudiesdemonstrated that the
cell titer glo assay did not interfere with the spectrophotometric
quantitation of melanin (data not shown). In order to identify genes
that impact both pheomelanin and eumelanin production, we
measured melanin content at 405 nm [25], a wavelength at which
both pheomelanin and eumelanin absorb light.
Raw A405nm absorbance values were normalized to internal
reference samples on each plate to permit plate-to-plate compar-
isons. This analysis was followed by normalization to the
experimental mean for each well location calculated from the full
data set in order to control for variations in pigment due to plate
position effects. Similarly adjusted luminescence values from the
multiplexed viability assay were used to generate ‘‘normalized
absorbance ratios’’ for each well (Table S1). The distribution of the
means of these values from duplicate analyses is shown in Figure
S1B. Previous studies have identified 68 genes that regulate
pigment production in human cells. Initial examination of our
dataset determined that siRNAs directed towards 13 of these 68
genes impaired melanin accumulation without impacting melano-
cyte survival or proliferation when depleted in these assays, with
tyrosinase itself scoring with one of the lowest ratios (2.5 standard
deviations below the mean; Table S2). Our current siRNA
screening protocol relies on siRNA design algorithms to identify
effective siRNA sequences and utilizes a single endpoint assay to
identify siRNAs that impact pigment production. Genes whose
function is not inhibited by selected siRNAs either secondary to
the long half-life of the corresponding protein or secondary to poor
siRNA sequence selection would not be identified in our screening
approach. Identification of several known regulators of melano-
genesis by our screening protocol does give confidence that our
approach is sufficiently robust to identify novel regulators of
pigment production.
To facilitate the identification of novel genes that significantly
impact melanogenesis, a cutoff of 2 standard deviations below the
mean was used to select a candidate hit list. 98 genes were
identified as regulators of melanogenesis by our screening
approach. Of these 98 genes identified in the primary screen,
only 6/98 genes (marked in red, Table 1) exhibited aberrant
expression in MNT-1 cells as compared to normal melanocytes
[19], indicating that the screen identified a large number of genes
that likely impacted melanogenesis in both primary melanocytes
and MNT-1 cells. Two of the genes identified in our screening
approach were more recently eliminated from the Refseq
database, and were not subject to detailed further evaluation.
Individually synthesized, pooled siRNAs directed against 35 of
the 96 remaining genes selected from the primary screen, as
described above, were retested to determine the false-positive rate
(Table S4). These genes were randomly selected from the putative
target list. To more precisely control for the efficacy of siRNA
transfection and to correct for the background absorbance of
MNT-1 cells, the ability of each target siRNA to inhibit pigment
production was compared to the ability of tyrosinase siRNA to
inhibit pigment production using a normalized percent inhibition
calculation [26], and relative pigmentation was assessed visually
prior to cell lysis (Figure 1A,B). A Keratin 7 siRNA pool that did
not impact pigment production was utilized as a negative control.
Four siRNA pools failed to significantly impact pigment
production upon retesting and were eliminated from further
analysis (Figure 1A, Table S4), giving an estimated false discovery
Author Summary
Aberrant pigment regulation correlates with skin disorders,
opthalmologic disorders, and neurologic disorders. While
extensive studies have identified regulators of mouse coat
color, the regulation of human skin phenotypic variation is
less well understood. To give a broader picture of the
molecular regulators of melanogenesis in human cells, we
used a genome-wide siRNA functional genomics approach
to identify 92 novel regulators of melanin production in
heavily pigmented MNT-1 melanoma cells. Our screen
identified several genes that converge to regulate
tyrosinase, the rate-limiting step in pigment production,
in both MNT-1 cells and primary melanocytes. Some of the
identified genes were selectively active in different genetic
backgrounds, suggesting that they may regulate human
phenotypic variation. Small molecule inhibition of a family
of novel pigment regulators was sufficient to impair
pigment production in melanocytes. Additionally, our
screen identified molecular machinery known to support
autophagosome biosynthesis as putative regulators of
melanogenesis. In vitro co-localization studies and autoph-
agy-deficient mice provided evidence that normal mela-
nogenesis requires the same molecular machinery used by
the autophagy pathway. Taken together, these results
illustrate the utility of genome wide siRNA screening
approaches for identifying genes, novel pharmacologic
agents, and pathways that regulate differentiated cellular
phenotypes.
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Category Symbol Comments Motifs
autophagy MAP1LC3C MAP1_LC3
WIPI1 expressed in melanoma cell autophagosomes WD40
GPSM1 GoLoco
GPCR GNG2 GGL
GPR113 GPS, 7tm_2
EDNRA linked to migraine resistance 7tm_1
OR4F15 7tm_1
EDG7 7tm_1
GPR92 7tm_1
AGTR2 linked to mental retardation 7tm_1
GRM7 ANF_receptor, NCD3G, 7tm_3
GPR84 7tm_1
P2RY1 7tm_1
transcription PLAGL1 mutation causes Beckwith-Wiedeman syndrome Znf_C2H2
EZH1 SANT, SET
TEF maps to pigment mutations in mice BRLZ
GATAD2A
ILF2 DZF
SMARCC2 CHROMO, SWIRM, SANT
pigment TYR Albinism Tyrosinase
BMP1 ZnMc, CUB, EGF_CA
phospholipid PNPLA4 Patatin
signaling ZFYVE1 FYVE
ITPK1 maps near SNPs linked to pigmentation Ins134_P3_kin
PLCXD1 PLCc
NRGN IQ
PLEKHA1 linked to age related macular degeneration PH
Ras family RAB4A RAB
GTPase HRASLS NC
ARL4A ARF, small_GTPase
ZDHHC9 linked to mental retardation zf-DHHC
C5ORF5 RhoGAP
ARHGEF11 PDZ, RGS, PH, RhoGEF
KLC4 Rab5-bind, TPR
protease SERPINB2 SERPIN
inhibitor WFDC8 WAP, KU
SERPINE1 SERPIN
SERPINB1 SERPIN
metabolism NT5E Metallophos, 5_nucleotid_C
G6PC3 AcidPPc
UROD mutation causes porphyria cutanea tarda URO-D
HPD mutation causes tyrosinemia type III glyoxalase
ALDH9A1 Aldedh
PLTP BPI1, BPI2
MSRA downregulated in vitiligo (hypopigmentation) PMSR
SMOX Amino_oxidase, DAO
UEVLD UBCc, Ldh_1_N, Ldh_1_C
GMPPB NTP_transferase, Hexapep
ALDH1A1 expression lost in Parkinson’s disease Aldedh
MGC4172 adh_short, Epimerase, KR
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ENO2 Enolase_N, Enolase_C
protein NLK S_TKc
phosphorylation PKN2 Hr1, C2, S_TKc, S_TK_X
RIOK1 RIO
PPP1R15A expression lost in melanoma transformation
PPP2CB PP2Ac
helicase RTEL1 DEXDc, HELICc
LOC389901 Ku, SAP DNA bd
peptidase ARTS-1 Peptidase_M1
KLK13 Tyrp_SPc
LYZ Amyloidosis LYZ1
ADAM19 Pep_M12B_propep, Reprolysin, DISIN, ACR, EGF_2
CPZ FRI, Zn_pept
TRY1 Tryp_SPc
SENP1 DSS1_SEM1
SHFM1 split hand/foot malformation Peptdiase_C48
translation EEF1A1 GTP_EFTU, GTP_EFTU_D2, GTP_EFTU_D3
VARS2 tRNA-synt_1, Anticodon_1
other NPM3 nucleoplasmin
STX18 syntaxin
KRTAP4-11 Keratin_B2
FGF23 overexpressed in hyperpigmentation syndrome FGF
SFRS2 RRM
SLC17A5 mutation causes Salla disease MFS_1
unknown USHBP1
UBE2V1 UBCc
TEX11 TPR_2
TANC2 ANK, TPR
FATE1
LRRC1 LRR
RTN3 Reticulon
SPATA22
ETAA1 tumor antigen, melanoma of soft parts
c12orf49
FAM125B
HSPC049 WD40
AFAP1L2 PH
FLJ41423
MAGEA6 melanoma antigen MAGE
MUC3b EGF, SEA
C1orf194 NuA4
FAM89B
Our siRNA-based screening approach identified 98 siRNAs that significantly inhibited pigment production. 4 of these 98 genes did not retest, while two of the 98 genes
were removed from the Refseq database. Gene Ontology databases were used to segregate the 92 remaining genes into function classes and identify conserved
domains within the corresponding proteins. Gene ontology databases, OMIM, and Pubmed searching was utilized to identify associations between our genes and
human diseases. Genes in our candidate list that are aberrantly expressed in MNT-1 cells as compared to normal melanocytes are shown in bold.
doi:10.1371/journal.pgen.1000298.t001
Table 1. cont.
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PLoS Genetics | www.plosgenetics.org 4 December 2008 | Volume 4 | Issue 12 | e1000298Figure 1. Validation of novel gene products supporting melanogensis. A) MNT-1 cells were transfected with the indicated siRNA pools (50
nM final concentration) targeting 35 of the 94 positive regulators of melanogenesis identified in the primary screen. siRNAs targeting Ker7, a gene
that does not impact pigment production, were used as a negative control (black bar). A normalized percent inhibition calculation [26] was employed
to compare the consequences of each siRNA pool on pigmentation with that observed upon depletion of tyrosinase. Bars represent mean and s.e.m.
for n=3. Red bars indicate failure to significantly suppress pigmentation. The results of the analysis of these 35 genes are shown in this panel (those
genes that were not putative autophagy regulators) and in Figure 3 (putative autophagy regulators). A summary of the results for all 35 genes is
shown in Table S4. B) A light micrograph of a representative opaque-walled, clear-bottomed 96-well microtiter plate containing MNT-1 cell
monolayers 7 days post transfection with the indicated siRNAs is shown. C) Four independent siRNAs targeting the indicated genes (see Table S3 for
siRNA sequence information) were separately tested for the capacity to suppress pigmentation as in (A). Associated p-values (student’s t-test) are
reported in Table S4.
doi:10.1371/journal.pgen.1000298.g001
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expression of the gene of interest, we utilized quantitative RT PCR
to examine if a random selection of candidate siRNA pools
inhibited the expression of the appropriate target gene (Figure S2).
These results validate that the siRNAs selectively impact the
expression of the cognate target gene, although this may not
conceivably hold true for all of the siRNAs used in our screen. To
eliminate siRNA pools with off-target effects on melanogenesis
[24], the four siRNAs comprising each siRNA pool were retested
individually. We found that at least two independent siRNAs
against each target gene significantly inhibited pigment production
(Figure 1C, Table S4), suggesting that pigmentation phenotypes
are not a common consequence of siRNA off-target phenomena.
Together, these studies demonstrate that the genome wide siRNA
screening platform accurately identified gene targets that specif-
ically impact pigment production.
Initial examination of existing GO annotation data for our
pigment regulators exposed a wide variety of cellular processes
represented by the validated and candidate hits (Table 1).
Therefore, we employed a focused unbiased approach to identify
regulators of tyrosinase, the rate limiting enzyme specifying
melanogenesis [15] among novel validated genes supporting
MNT-1 pigmentation. Relative accumulation of tyrosinase, the
melanogenesis transcription factor MITF, and the melanosomal
marker protein Melan-A were examined 96 hours post siRNA
transfection. Remarkably, over half of the validated pigment genes
appear to be required for tyrosinase protein accumulation
(Figure 2A, Figure S3). This defect did not appear to be a gross
inhibition of cell fate specification, as Melan-A expression was
mostly unaffected. In addition, the sub cellular morphology of
PMEL17, a melanosome structural protein [27], was normal at the
level of immunofluorescence detection (Figure S4). Of those
pigment genes impacting tyrosinase accumulation, approximately
half appear to act at the level of tyrosinase mRNA accumulation
(Table 2), and most of these also impaired MITF mRNA
accumulation. Given that tyrosinase is an MITF target gene, the
pigmentation genes in this later class may represent action at the
level of MITF mRNA. A caveat to this interpretation is our
observation that siRNA-mediated turnover of tyrosinase mRNA
can also lead to inhibition of MITF gene expression (Figure 2A)
through a relationship that remains to be defined. Preliminary
studies indicated that this phenotype was not a consequence of
siRNA off-target phenomenon (Figure S3).
While pigmentation in humans is a complex multigenic trait, the
degree of genetic variation that contributes to melanocyte
autonomous pigment production is unknown. To examine the
phenotypic penetrance of novel pigmentation genes, identified in
MNT-1 cells, in diverse genetic backgrounds, we employed primary
human melanocyte cultures isolated from two different individuals.
Remarkably, the majority of targets that regulated tyrosinase
expression in MNT-1 cells also impacted tyrosinase expression
when depleted from darkly pigmented primary melanocytes
(Figure 2C, Figure S5A). Approximately half of these targets also
inhibited tyrosinase expression when depleted from moderately
pigmented melanocytes (Figure 2C, Figure S5B). These results
indicate that the primary screen identified a number of genes that
impact pigment production in several different genetic backgrounds.
Selective activity of some of these targets in different genetic
backgrounds suggests that some of these novel regulators of
melanogenesis may play a role in human phenotypic variation.
Future large scale studies are required to determine if these genes are
differentially expressed in different pigment backgrounds.
For further analyses, we focused on those novel pigmentation
genes that impacted tyrosinase expression in all three genetic
backgrounds. Among these were two isoforms of aldehyde
dehydrogenase, ALDH1A1 and ALDH9A1, well characterized
enzymes that regulate ethanol detoxification [28]. A number of
chemical inhibitors of these enzymes have been identified [29],
and several of these agents are clinically utilized to induce alcohol
intolerance during detoxification interventions; presenting an
opportunity for pharmacological validation of the contribution of
Aldh activity to melanocyte pigmentation. Disulfiram is an Aldh
inhibitor that is toxic to melanoma cells via a mechanism that is
independent of Aldh inhibition [30]. However, two non-toxic Aldh
inhibitors, cyanamide and Angeli’s salt [29], inhibited pigmenta-
tion and tyrosinase protein accumulation in MNT-1 cells at doses
that are equivalent to those required for inhibition of Aldh activity
in culture (Figure 2D). For quantifying the impact of compound
treatment on pigment accumulation, we used our spectrophoto-
metric-based melanin quantitation assay that couples a CellTiter-
Glo assay with a melanin quantitation assay to effectively eliminate
compounds that impact cell survival or proliferation. Cyanamide
did not appear to impact the viability of MNT-1 cells or primary
melanocytes in culture. In addition, these compounds impaired
UV-induced tyrosinase expression when tested in primary
melanocytes (Figure 2D,E).
Melanosomes are distinct lysosome-related organelles depen-
dent upon appropriate post-golgi sorting events for delivery of
functionalizing ‘cargo’ including tyrosinase [31]. Therefore,
impaired accumulation of tyrosinase can be a consequence of
misrouting to lysosomes and subsequent hydrolysis in that
organelle. To define target genes that may participate in this
sorting event, lysosome acidification was inhibited by bafilomycin
A1 exposure subsequent to target gene depletion [32]. As shown in
Figure 3A, a 24 hour inhibition of lysosome acidification rescued
tyrosinase accumulation upon depletion of the small G-protein
RAB4A, and the small G-protein palmitoyltransferase ZDHHC9.
By contrast, bafilomycin did not restore tyrosinase accumulation
upon depletion of MSRA, a protein that can protect against
oxidative damage through reduction of methionine sulfoxide.
These studies offered preliminary evidence that our screening
approach did identify novel genes that impact melanosome
trafficking/sorting of melanosome protein cargo.
Gene annotation data was utilized to identify other genes that
may regulate melanosome intracellular trafficking/sorting of
melanosome protein cargo. Among the panel of validated pigment
regulatory genes with phenotypic penetrance in multiple genetic
backgrounds was WIPI1 (Figure 2). Wipi1 has been implicated as
a human homolog of the yeast autophagy protein ATG18, and is
localized to starvation-induced autophagosomes in human cell
culture [33]. Two additional autophagy-related proteins, LC3-C
and GPSM1/AGS3 were isolated in the primary screen (Table 1).
Autophagy, or cellular self-degradation, is a highly conserved
cellular pathway that has been associated with cancer formation,
neurodegeneration, and aging [34–36]. This pathway functions to
transport vesicle cargo (autophagosomes) to the lysosome for
degradation [35]. Scant evidence currently exists linking autoph-
agy to melanogenesis. Previous studies have documented an
abundance of autophagosomes in cells obtained from patients with
a disorder of pigmentation (HPS-1) but have hypothesized that
their presence is a consequence of the degradation of immature
melanosomes within these cells [37]. Other studies have
determined that autophagosome components are present in the
stage II melanosome, suggesting that parts of the melanosome
originate from the autophagosome [38].
Our genome wide siRNA screen directly identified autophagy
components as novel regulators of melanogenesis. Validation of
these targets by siRNA pool deconvolution supported a functional
siRNA-Based Functional Genomics of Pigmentation
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(Figure 3B). Furthermore, we found that depletion of two
additional components required to trigger autophagosome forma-
tion, BECN1 or LC3-A, severely impaired pigment accumulation
(Figure 3B). Failure to recover these genes in the primary screen is
indicative of the false negative rate inevitably associated with high
throughput investigations and illustrates the point that our
approach is unlikely to identify all known regulators of
Figure 2. Novel, pharmaceutically-tractable melanogenesis gene networks converge on tyrosinase expression. A) 4 days post
transfection with the indicated siRNAs, MNT-1 whole cell lysates were prepared and analyzed by immunoblot for the indicated proteins. A non-
targeting siRNA was used as a transfection control (Control). ERK1/2 is shown as a loading control. B) Those siRNAs that inhibited tyrosinase
accumulation were examined for consequences on tyrosinase and MITF gene expression by quantitative RT-PCR. 72 hours post transfection with the
indicated siRNAs, equal numbers of MNT-1 cells were lysed and cDNA was prepared using a Cells to Ct kit (Ambion). Taqman qRT PCR assays (Applied
Biosystems) for tyrosinase and MITF was utilized to identify siRNAs that impacted tyrosinase and MITF expression. C) The indicated siRNAs, targeting
novel pigmentation genes identified in the MNT-1 screen, were tested for consequences on tyrosinase accumulation in darkly pigmented and
moderately pigmented primary human melanocyte cultures 6 days post-transfection. The results presented here is a venn diagram of the data
presented in Figure S5 demonstrating that we have identified pigment regulators that differentially impact pigment production in different genetic
backgrounds. D) Pharmacological inhibition of Aldh activity impacts tyrosinase protein accumulation. MNT-1 cells (left panel) and primary melanocyte
cultures (right panels) were exposed to 5 mM Aldh inhibitors (cyanamide or Angeli’s salt) or the tyrosinase inhibitor hydroquinone [15] for 72 hours as
indicated. 24 hours post-treatment, cultures were exposed to UV-B at the doses indicated. Tyrosinase and ERK1/2 levels were assessed by
immunoblot. MNT-1: Angeli’s salt (5 mM), cyanamide (5 mM), or hydroquinone (5 mM); primary melanocytes: Angeli’s salt (50 mM), cyanamide
(100 mM), hydroquinone (1 mM). E) Aldh inhibitors impair melanogenesis in primary human melanocytes. Darkly pigmented melanocytes were
cultured for seven days in the presence of the indicated dosed of cyanamide (cya), vehicle, or PTU. PTU is the most potent currently known in vitro
pigment inhibitor in primary melanocytes [43]. Subsequently, cells were lysed in CellTiter-Glo and the luminescence and absorbance values were
used to calculate inhibition of pigmentation as in Figure 1A.
doi:10.1371/journal.pgen.1000298.g002
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Lc3 impact pigment accumulation is supporting evidence that
autophagy impacts melanogenesis. Consistent with this relation-
ship, heterozygous deletion of the autophagy protein Beclin 1 [39]
results in a dramatic coat color defect in mice (Figure 3C, Figure
S6). Homozygous null mutations are embryonic lethal, however
haploinsufficient animals show an interesting chimeric phenotype
with normal and hypopigmented hair follicles. The hypopigment-
ed follicles in these mice contain less pigment in the hair follicle
bulb as observed on horizontal sections of the hair follicle.
Previous studies have determined that only melanoblasts within
the hair follicle unit express S100b protein [40]. To determine if
the phenotype observed in beclin1 haploinsuffiicient mice is
secondary to an impact of beclin1 depletion on melanoblast
survival, we attempted to identify S100+ melanoblasts within the
hair follicle in horizontally sectioned skin specimens of wild type
and Beclin1 haploinsufficient mice. Consistent with published
studies, it was difficult to identify S100 positive cells within the hair
follicle of wild type mice secondary to interfering melanin [40].
However, in Beclin1 haploinsufficient mice, we determined that
S100+ cells were present in the hair follicle (Figure 3D). Data from
our siRNA screen indicated that beclin1 depletion does not impact
melanocyte survival. Taken together, our siRNA data and
histologic analysis suggests that the phenotype observed in the
Beclin1 haploinsuficient mice is not a consequence of impacts of
Beclin1 on melanocyte survival but is more likely secondary to the
impact of beclin1 on melanosome number or melanin content
within the hair follicle. As melanosomes are thought to be
lysosome related organelles, autophagic machinery may be
required for the functional sorting of melanin synthetic machinery.
At the cell autonomous level, we found co-localization of the
autophagy proteins LC3 and APG5 and the melanosome markers
PMEL17 in mature melanosomes (Figure 3E). Thus molecular
components required for autophagosome formation are directly
implicated in the biogenesis of melanin, either at the level of
melanosome formation or melanosome maturation. When cou-
pled with previous data demonstrating that autophagosomes
accumulate in cells defective in melanosome maturation, these
results indicate that the autophagy pathway is intimately involved
in the process of melanosome maturation [37].
We have utilized an unbiased, high-throughput functional
genomics screening platform to identify critical single gene loci that
regulate the notoriously complex, highly regulated process of
melanogenesis in human cells. Using this approach, we have
identified 92 novel genes that impact pigment production in human
cells. The convergence of several of these loci directly on the critical
rate-limiting enzyme in melanogenesis, tyrosinase, underscores the
power of this approach to identify unrecognized genes that are
components of even well characterized enzymatic pathways. The
complexity of the network controlling tyrosinase expression uniquely
parallels the variation in skin color seen in human skin, underscored
by the fact that these mechanisms are differentially active in
moderately and darkly pigmented melanocytes. The direct identi-
fication of novel pigment modulatory agents highlights the utility of
genome wide siRNA screening as a translational approach for
deriving novel molecular based treatment strategies.
Methods
Cell Culture and Reagents
MNT-1 cells were a gift of M. Marks (University of
Pennylvania). These cells were cultured in DMEM (Invitrogen)
with 15% fetal bovine serum (Hyclone), 10% AIM-V medium
(Invitrogen), 1xMEM (Invitrogen) and 16 antibiotic/antimycotic
(Invitrogen). Darkly pigmented and moderately pigmented
melanocytes were purchased from Cascade Biologics. These cells
were cultured in Medium 254 with the melanocyte specific HMGS
supplement (Cascade Biologics). Beclin 1 heterozygous mice were
obtained from Beth Levine. Angeli’s salt was a gift from Pat
Farmer. Cyanamide was purchased from Sigma. Bafilomycin A1
was purchased from Tocris Biosciences. The genome wide siRNA
library used in these studies was previously described [24]. RPMI
1640 (Invitrogen) was media used for creating lipid oligonucleotide
mixtures. All transfections utilized Dharmafect-2 transfection
reagent (Dharmacon). For western blotting we utilized the
following antibodies: tyrosinase (Santa Cruz Biotechnology, cat
# sc-7833), MITF (Santa Cruz Biotechnology, sc-56725), Erk1
(Santa Cruz Biotechnology, sc-94), and Melan-A (Santa Cruz
Biotechnology, sc28871). Primary antibody dilutions used in these
studies ranged form 1:200 to 1:1000 and anti mouse or anti rabbit
HRP antibodies (Santa Cruz Biotechnology) were used in the
Table 2. Genome-Wide siRNA Screening Identifies Targets
That Differentially Impact Tyrosinase and MITF Expression.
Phenotype Symbol MITF Tyrosinase Melan A
. TYR and MITF TYR . RNA . RNA NO CHANGE
mRNA WIPI1 . RNA . RNA . PROTEIN
ALDH1A1 . RNA . RNA NO CHANGE
ALDH9A1 . RNA . RNA NO CHANGE
PLEKHA1 . RNA . RNA . PROTEIN
RAB4A . RNA . RNA m PROTEIN
SERPINB2 . RNA . RNA m PROTEIN
MSRA . RNA . RNA NO CHANGE
NPM3 . RNA . RNA m PROTEIN
. MITF mRNA ARHGEF11 . RNA . PROTEIN NO CHANGE
. TYR protein ZDHHC9 . RNA . PROTEIN NO CHANGE
ITPK1 . RNA . PROTEIN . PROTEIN
. MITF mRNA AGTR2 . RNA NO CHANGE NO CHANGE
. TYR protein PPP1R15A . PROTEIN . PROTEIN NO CHANGE
ZFYVE1 NO CHANGE . PROTEIN NO CHANGE
. MITF protein GNG2 . PROTEIN NO CHANGE NO CHANGE
no change in EDNRA NO CHANGE NO CHANGE m PROTEIN
MITF or TYR SMARCC2 NO CHANGE NO CHANGE NO CHANGE
FLJ1123 NO CHANGE NO CHANGE NO CHANGE
UROD NO CHANGE NO CHANGE NO CHANGE
UEV3 NO CHANGE NO CHANGE NO CHANGE
ARL4A NO CHANGE NO CHANGE NO CHANGE
P66A NO CHANGE NO CHANGE NO CHANGE
OR4F15 NO CHANGE NO CHANGE NO CHANGE
Western blotting and quantitative RT-PCR was used to identify siRNAs that
impact tyrosinase, MITF, and Melan-A protein levels or impact tyrosinase and
MITF mRNA levels in MNT-1 cells (Figure 2 A, B). siRNAs that significantly
impacted the expression of MITF and tyrosinase mRNA as determined by
quantitative RT-PCR (p,.05 by student’s t-test) and protein as determined by
western blotting, or siRNAs that only impacted protein accumulation as
determined by western blotting (densitometry values less than 50%) are shown.
Genes are sorted into several phenotypes: genes that regulate tyrosinase and
MITF protein and mRNA accumulation, genes that regulate MITF mRNA
accumulation but only tyrosinase protein accumulation, genes that regulate
MITF mRNA accumulation but not tyrosinase or melan-a protein accumulation,
genes that regulate protein but not mRNA accumulation of tyrosinase or MITF,
and genes that did not impact protein accumulation of tyrosinase or MITF.
doi:10.1371/journal.pgen.1000298.t002
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PLoS Genetics | www.plosgenetics.org 8 December 2008 | Volume 4 | Issue 12 | e1000298Figure 3. Autophagy is a novel biological process regulating melanin production. A) MNT-1 cells transfected with the indicated siRNAs (50
nM) were incubated in the presence and absence of bafilomycin A1 for 24 hours prior to lyses and analyses of tyrosinase protein accumulation. All
results shown are representative of a minimum of three independent experiments. B) MNT-1 cells were transfected with the indicated siRNA pools (50
nM final concentration) or individual siRNAs (75 nM final concentration) targeting putative genes that regulate autophagy identified in the primary
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described below. S100B antibody was purchased from DakoCy-
tomation.
High Throughput Transfection Protocol
High throughput transfection was performed essentially as
described [24] with slight modifications. 0.28 pmoles of each
siRNA pool in a volume of 30 ul of RPMI was delivered to each of
6 assay plates/master plate using a Biomek FX robotic liquid
handler (Beckman Coulter). 0.1 ul of Dharmafect 2 (Dharmacon)
in 9.9 ul of RPMI was then delivered to each well using a TiterTek
Multidrop. Following a 20–30 minute incubation, 1610
4 MNT-1
cells from a trypsin-mediated single-cell suspension were delivered
to the siRNA/liposome complexes in a total volume of 200 ul.
Plates were incubated for 120 hours at 37uC/5% CO2 after which
a Hydra 96 (Robbins-Scientific) was used to removed 100 ul of the
medium. 15 ul of CellTiter-Glo Reagent (CTG) (Promega) was
delivered to each well and incubated according to manufacturer
protocol. Luminescence and absorbance values for each well was
recorded using an Envision Plate Reader (Perkin Elmer). Each
transfection was performed in duplicate.
Data Normalization
Raw luminescence values collected from the high throughput
screen were normalized to internal reference control samples (cells
with no siRNA in wells A1–A8) on each plate to allow for plate-to-
plate comparisons. These values were used to normalize
absorbance values for each well in the plate, effectively controlling
for the impact of each siRNA on cell viability. To normalize for
positional variation in the plates secondary to prolonged culture
times in the humidified incubator, each well in the plate was
normalized to the mean value from all wells in the same location.
Mean and standard deviation for each data point and the mean
and standard deviation of the entire distribution was calculated.
siRNAs that produced absorbance/CellTiter-Glo ratios two
standard deviations below the mean were subjected to further
analysis.
Quantitative RT-PCR
4610
3 MNT-1 cells were transfected in 96 well plates with 50 nM
candidate siRNA using 0.2 ul dharmafect 2 reagent. 48 hours after
transfection, cDNA was prepared from transfected cells utilizing a
Cells to Ct kit (Ambion) per the manufacterer’s protocol. Primers
targeting each candidate gene, tyrosinase, actin and MITF were
purchased from Applied Biosystems. An aliquot of each cDNA
reaction was then added to each Taqman master mix reaction along
with the appropriate primer per the manufacturer’s protocol
(Applied Biosystems). A 7900HT Fast Real-Time PCR System
(Applied Biosystems) was utilized to determine Ct values. Values
were normalized using actin and analyzed using the relative
quantification mathematical model (Pfaffl).
Drug Treatment
1610
4 MNT-1 cells were plated in a 96 well microtiter plate.
24 hours after plating, cells were incubated with vehicle,
hydroquinone Angeli’s salt, or cyanamide. 48 hours after drug
treatment, cell lysates were prepared and subjected to immuno-
blotting with a tyrosinase and ERK antibody. Similar protocols
were utilized in primary melanocytes. Melanocytes were plated in
96 well microtiter plates in the presence of drug or vehicle.
24 hours after drug treatment, melanocytes were treated with UV.
Cell lysates were prepared 24 hours after UV treatment and
subjected to immunoblotting. In order to measure an impact of
cyanamide on pigment production in melanocytes, primary
melanocytes were incubated in the presence of vehicle, phenyl-
thiourea, or increasing concentrations of cyanamide. Cells were
incubated for an additional 7 days, with one media change on day
4, prior to collection of absorbance and viability values. For
bafilomycin experiments, MNT-1 cells were transfected with 75
nM siRNA in 12 well plates. 80 hours after transfection, 25nM
bafilomycin was added. 96 hours after transfection cell lysates
were prepared and subjected to immunoblotting.
Immunofluorescence
For immunoflourescence detection of melanosome and autoph-
agy markers, cells were fixed in 2% paraformaldehyde for 1 hour.
Coverslips were washed in PBS, cells were permeabilized with
0.1% Triton-X-100 (MNT-1 cells) or 0.4% saponin (primary
melanocytes), and blocked in 1% BSA with 0.1% Tween 20. Cells
were incubated with the following primary antibodies: Pmel17
(HMB50, Lab Vision Corporation, 1:100 dilution), Apg5 (Santa
Cruz Biotechnology, sc-33210, 1:50 dilution), and LC3b (Santa
Cruz Biotechnology, sc-28266, 1:50 dilution), for 1 hour. The
secondary antibodies used in this study were Alexa Fluor 514 and
594 purchased from Invitrogen. Coverslips were incubated in a
1:1000 dilution of the corresponding secondary antibody for
1 hour. Confocal images were acquired using a LSM-510 meta
confocal multiphoton microscope.
Mice
Beclin1 haploinsufficient mice were generated as described. [39]
All studies involving beclin1 +/+ and beclin1 +/2 mice utilized
animals that had been backcrossed with C57BL/6J for a minimum
of six generations. Representative pictures and figures contained in
the manuscript were generated from littermates.
Immunohistochemistry
Mouse skin sections from four wild type and four beclin 1
haploinsufficient mice were fixed in formalin and paraffin embedded.
Haematoxylin and eosin staining were performed following standard
protocols. Melanin was stained using the Masson-Fontana technique
with a neutral red counterstain [41]. S100 staining was performed as
described using an eosin counterstain [42].
screen as described in Figure 1. WIPI1, LC3-C, and GPSM1 were genes identified in the original dataset, while BECN1 and MAP1LC3C are known
regulators of autophagy not identified in our initial screening approach. Bars represent mean and s.e.m. for n=3. Associated p-values (student’s t-
test) are reported in Table S4. C) Coat color defects in autophagy impaired mice. The coat pigmentation of C57B6 wild type (+/+) (mouse on the right)
and heterozygous Beclin 1 mutant littermates (+/2) (mouse on the left) is shown. D) Reduced melanin accumulation in the hair follicles of Beclin1
haploinsufficient mice.. Skin samples from Beclin 1 haploinsufficient mice and wild type littermates were fixed and horizontally sectioned. Upper
panels: Fontana-Masson silver staining was used to assess melanin content in the hair follicle (arrow). Detection of staining in wild-type folliclesi s
obscured by accumulation of opaque pigment granules (left panel, and occasional normal follicles in the Beclin+/2 background (arrow head)).
Sections were counter-stained with aqueous neutral red. Lower panels: the melanoblast marker S100b was used to identify melanocytes in the hair
follicle bulb (arrow). Again, staining is obscured in normal follicles due to accumulation of opaque pigment granules. E) MNT-1 cells were fixed and
stained with the primary antibodies indicated. Two-photon confocal microscopy was utilized to visualize the colocalization of autophagy and
melanosome markers. Representative 0.2 mM confocal slices are shown.
doi:10.1371/journal.pgen.1000298.g003
siRNA-Based Functional Genomics of Pigmentation
PLoS Genetics | www.plosgenetics.org 10 December 2008 | Volume 4 | Issue 12 | e1000298Supporting Information
Figure S1 Genome-wide RNAi screening for novel molecular
components of melanogenesis. A) A MNT-1 model for loss-of-
function detection of pigmentation genes. MNT-1 cells were
transfected with siRNAs targeting tyrosinase using a microtiter-plate
based high throughput reverse transfection protocol [24] optimized
forthiscellline.Inhibitionofpigmentation andtyrosinase expression
relative to control non-targeting siRNAs is shown. B) MNT-1
pigmented melanoma cells were transfected with 84,920 siRNA
duplexes targeting 21,230 genes in a one-well, one-gene reverse
transfection format as we have previously described [24]. 120 hrs
post transfection, Raw A405nm absorbance values were collected for
each well and normalized to internal reference samples on each
plate, followed by normalization to the experimental mean for each
well calculated from the full data set to control for variations in
pigment due to plate and position effects. Similarly adjusted
luminescence values from a multiplexed viability assay (CellTiter-
Glo) were used to control for cell number, generating ‘‘normalized
absorbance ratios’’ for each well (absorbance/cell number; Table
S1). The log2 transformation of the average normalized absorbance
ratios among replicates is shown for each gene from lowest
(hypopigmentation) to highest (hyperpigmentation). Values below
2 standard deviations from the mean are shown in red.
Found at: doi:10.1371/journal.pgen.1000298.s001 (2.28 MB TIF)
Figure S2 Quantitative RT-PCR was employed to measure the
impact of select pooled siRNAs on target mRNA levels. Actin
primers were employed to control for mRNA concentrations.
Results are representative of three experiments performed in
triplicate. A student’s t-test was utilized to validate that siRNAs
significantly inhibited the expression of the corresponding gene.
All of the siRNAs tested in this analysis significantly inhibited the
expression of the corresponding gene (p value,.05).
Found at: doi:10.1371/journal.pgen.1000298.s002 (2.28 MB TIF)
Figure S3 The impact of multiple independent siRNAs,
targeting the indicated genes, on tyrosinase protein accumulation
was assessed by immunoblot. The impact of a given siRNA on
gene expression was quantitated by densitometry (numbers below
the corresponding blots). Two or more siRNAs impaired
tyrosinase protein expression in all cases examined. Similarly,
the impact of multiple independent siRNAs targeting tyrosinase on
MITF protein accumulation was assessed by immunoblot. All
three siRNAs tested had an impact on MITF expression.
Found at: doi:10.1371/journal.pgen.1000298.s003 (2.28 MB TIF)
Figure S4 MNT-1 cells transfected with the indicated siRNAs
were immunostained with anti-Pmel antibodies to detect melano-
somes 4 days post transfection. Representative micrographs are
shown.
Found at: doi:10.1371/journal.pgen.1000298.s004 (2.28 MB TIF)
Figure S5 Identified pigment regulators differentially regulate
tyrosinase expression in different genetic backgrounds. A) The
indicated siRNAs targeting novel pigmentation genes identified in
the MNT-1 screen were tested for consequences on tyrosinase
protein accumulation in darkly pigmented primary human
melanocyte cultures 6 days post transfection. A non-targeting
siRNA was used as a transfection control (Control). ERK1/2 is
shown as a loading control. B) The indicated siRNAs, targeting
novel pigmentation genes identified in the MNT-1 screen, were
tested for consequences on tyrosinase protein accumulation in
moderately pigmented primary human melanocyte cultures 6 days
post transfection as in (A). A venn diagram in Figure 2 identifies
sets of genes that differentially impact tyrosinase accumulation in
different genetic backgrounds.
Found at: doi:10.1371/journal.pgen.1000298.s005 (2.28 MB TIF)
Figure S6 Autophagy deficient mice have coat color defects.
Photograph depicts the coat color of 4 wild type and 4 beclin 1
haploinsufficient littermates. Note that no pigmentary defects are
noted on the nose which argues against defects in melanoblast
migration. Mice are of similar size. Additionally, no pigment
defects were noted on the belly.
Found at: doi:10.1371/journal.pgen.1000298.s006 (2.28 MB TIF)
Table S1 Genome-wide siRNA dataset. MNT-1 pigmented
melanoma cells were transfected with 84,920 siRNA duplexes
targeting 21,230 genes in a one-well, one-gene reverse transfection
format as we have previously described [24]. 120 hrs post
transfection, Raw A405nm absorbance values were collected for
each well and normalized to internal reference samples on each
plate, followed by normalization to the experimental mean for
each well calculated from the full data set to control for variations
in pigment due to plate and position effects. Similarly adjusted
luminescence values from a multiplexed viability assay (CellTiter-
Glo) were used to control for cell number, generating ‘‘normalized
absorbance ratios’’ for each well (absorbance/cell number). Data
for each individual absorbance ratio, the mean, and standard
deviation is shown for all of the genes examined. Additionally gene
ontology information for each gene, accession number, and
chromosome position is indicated.
Found at: doi:10.1371/journal.pgen.1000298.s007 (10.32 MB
XLS)
Table S2 Genome wide siRNA screen identifies known
regulators of melanogenesis. 127 mouse coat color genes have
been identified to date and 68 of these genes have human
homologues. To validate that our screening approach could
identify known regulators of melanogenesis, we identified genes in
the coat color database whose corresponding siRNAs significantly
inhibited pigment production in our assay. SiRNAs corresponding
to 13 of the 68 genes in this database significantly impacted
pigment production. Normalized pigment inhibition scores and
standard deviations are listed for each of these genes.
Found at: doi:10.1371/journal.pgen.1000298.s008 (0.02 MB
XLS)
Table S3 siRNA sequences that significantly inhibited pigment
production in our siRNA Screen. The corresponding sequences
for each of the four siRNA duplexes that collectively inhibited
pigment production in our siRNA library is shown.
Found at: doi:10.1371/journal.pgen.1000298.s009 (0.06 MB
XLS)
Table S4 Individual and pooled siRNAs Directed at novel
pigment regulators significantly impact pigment production.
Individual and pooled siRNAs directed towards 35 of the novel
regulators of pigment production identified in our genome wide
screen were retested to examine their impact on pigment
production (retest data for 32 genes is shown in figure 1, while
retest data for 3 remaining genes is shown in Figure 3). A student’s
t-test was used to determine if these siRNAs were able to
significantly inhibit pigment production when compared to a
control siRNA (Ker7). 4 of the siRNA pools retested did not
significantly inhibit pigment production. Two of the four oligos
retested for all of the other genes examined. Underlined numbers
correspond to p-values less than .05, while bold numbers
correspond to p-values less than .01. The results are representative
of a minimum of three experiments done in triplicate.
Found at: doi:10.1371/journal.pgen.1000298.s010 (0.04 MB
XLS)
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